Myocardial Characterization of Arrhythmogenic Mitral Valve Prolapse (STAMP: STretch and Myocardial Characterization in Arrhythmogenic Mitral Valve Prolapse)

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 239 participants.

Also called NCT02879825

  • Study
  • In this atlas

Overview

Design
Interventional study; non-randomized; no masking; primary purpose diagnostic
Phase
Not applicable
Enrolled
  • 239 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02879825
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
France (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02879825. Non-randomized; no masking; primary purpose diagnostic. Start 2016-12-20 (actual); primary completion 2021-05-31 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Myocardial Characterization of Arrhythmogenic Mitral Valve Prolapse (STAMP: STretch and Myocardial Characterization in Arrhythmogenic Mitral Valve Prolapse)
Acronym
STAMP
Condition
Mitral Valve Prolapse
Intervention (Device)
Cardiac MRI
Lead sponsor
Central Hospital, Nancy, France (class: other)

Record details

Record id
cardio:ct-nct02879825
Content hash
730743c84978cf4152b37274f94d73aa7723293977a808b99676e1d1ace80ab9